Acumen Pharmaceuticals Inc. (ABOS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acumen Pharmaceuticals In...

    NASDAQ: ABOS · Real-Time Price · USD
    1.44
    0.06 (4.35%)
    At close: Sep 05, 2025, 3:59 PM
    1.46
    1.39%
    After-hours: Sep 05, 2025, 07:53 PM EDT

    Acumen Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.01 -3.56 -5.12 -2.57
    PEG Ratio
    		 -0.02 -1.88 0.09 -0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.57 0.70 1.16 1.15
    P/FCF Ratio
    		 -1.2 -4.32 -6.21 -14.37
    P/OCF Ratio
    		 -1.2 -4.32 -6.24 -14.4
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.16 0.12 0.00 n/a
    Quick Ratio
    		 6.46 19.01 23.08 38.60
    Current Ratio
    		 6.46 19.01 23.08 38.60
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -28.03 -105.23 n/a n/a
    Return on Equity
    		 -0.56 -0.2 -0.23 -0.45
    Return on Assets
    		 -0.43 -0.17 -0.22 -0.44
    Return on Invested Capital
    		 -0.54 -0.2 -0.24 -0.09
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist